Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non small-cell lung cancer: A phase II study

British Journal of Cancer

Volumn 81, Issue 6, 1999, Pages 1031-1036

  Scinto, A F ^a   Ferraresi, V ^a   Milella, M ^a   Tucci, E ^b   Santomaggio, C ^c   Pasquali Lasagni, R ^a   Del Vecchio, M R ^a   Campioni, N ^a   Nardi, M ^a   Cognetti, F ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b Hospital S Maria dell Scala   (Italy)

^c Department of Nephrology USL Azienda 10   (Italy)

Author keywords

Chemotherapy; G CSF; ICE; Inoperable; Locally advanced; Non small cell lung cancer

Indexed keywords

ANTINEOPLASTIC ALKALOID; ANTINEOPLASTIC METAL COMPLEX; CHLORMETHINE DERIVATIVE; CISPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IFOSFAMIDE; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032698255     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690803     Document Type: Article

References (24)

1. American Joint Committee on Cancer (1992) Manual for Staging of Cancer, 4th edn, Beahrs OH, Henson DE, Hutter RVP and Kennedy BJ (eds). Lippincott: Philadelphia
2. Ardizzoni A, Fusco V, Gulisano M, Pronzato P, Bracco F, Capaccio A, Pastorino G, Nosenzo M, Felletti R, Fabiano F and Rosso R (1987) Etoposide, ifosfamide, and cisplatin in the treatment of advanced non small cell lung cancer. Cancer Treat Rep 71: 1311-1312
3. Bonomi P and Penfield FL (1997) Postoperative and preoperative chemotherapy for non-small-cell lung cancer. Cancer Control; J Moffitt Cancer Center 4: 297-306
4. Calabresi F, Papaldo P, Marolla P, Lopez M, Vici P, Di Lauro L, Pellegrini P, Foggi CM, Lepidini G, Antimi M, Terzoli E and Barone C (1995) Different schedules of G-CSF in adjuvant breast cancer therapy with high-dose epirubicin + cyclophosphamide ± lonidamine. Proc Am Soc Clin Oncol 14: 698 (abstract)
5. Choi NC (1983) Curative radiation therapy for unresectable non small-cell carcinoma of the lung: indications, techniques, results. In: Thoracic Oncology. Choi NC and Grillo HC (eds), pp. 163-199, Raven: New York
6. Eberhardt W and Nicderle N (1992) Ifosfamide in non-small cell lung cancer: a review. Semin Oncol 19: 40-48
7. Elias AD, Skarin AT, Leong T, Mentzer S, Strauss G, Lynch T, Shulman L, Jacobs C, Abner A, Baldini EH, Frei E III and Sugarbaker DJ (1997) Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer. Lung Cancer 17: 147-161
8. Fischer JR, Manegold C, Bülzebruck H, Vogt Moykopf I and Drings P (1994) Induction chemotherapy with or without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer. Semin Oncol 21: 20-27
9. Ginsberg RJ, Vokes EE and Raben A (1997) Non-small cell lung cancer. In: Cancer: Principles and Practice of Oncology, De Vita VT Jr, Hellman S and Rosenberg SA (eds), pp. 858-911. JB Lippincott: Philadelphia
10. Kaplan E and Meier P (1958) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53: 457-471
11. Martini N, Kris MG, Flehinger BJ, Gralla RJ, Bains MS, Burt ME, Heelan R, McCormack PM, Pisters KM and Rigas JR (1993) Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan Kettering experience with 136 pitients. Ann Thorac Surg 55: 1365-1374
12. Miller AB, Hoogstraten B, Staquet M and Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207-214
13. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer; a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311: 899-909
14. Paccagnella A, Favaretto A, Brandes A, Ghiotto C, Fornasicro L, Volpi A, Pappagallo, G, Festi G, Cipriani, Vinante O, Chiaron-Sileni and Fiorentino MV (1990) Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. Cancer 65: 2631-2634
15. Parkin DM and Saxo AJ (1993) Lung cancer: worldwide variation in occurrence and proportion attributable to tobacco use. Lung Cancer 9: 1-16
16. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, Perez-Tamayo R and Rotman M (1987) Long term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy: Report by the Radiation Therapy Oncology Group. Cancer 59: 1874-1881
17. Perez EA, Sowray PC, Gardner SL and Gandara DR (1994) Phase I study of high-dose cisplatin, ifosfamide, and etoposide. Cancer Chemother Pharmacol 34: 331-334
18. Pujol JL, Rossi JF, Le Chevalier T, Daures JP, Rouanet P, Douillard JY, Dubois JB, Arriagada R, Mary H and Godard P (1990) Pilot study of neoadjuvant ifosfamide, cisplatin and etoposide in locally advanced non-small cell lung cancer. Eur J Cancer Clin Oncol 26: 798-801
19. Rosell R, Gòmez-Codina J, Camps C, Maestre J, Padilla J, Cantò A, Mate JL, Li S, Roig J, Olazàbal A, Canela M, Ariza A, Skachel Z, Morera-Pratt J and Abad A (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330: 153-158.
20. Rosell R, Jòpez-Cabrerizo MP and Astudillo J (1997) Preoperative chemotherapy for stage IIIA non-small cell lung cancer. Curr Opin Oncol 9: 149-155
21. Roth JA, Fossella F, Komaki R, Ryan B, Putnam JB Jr. Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M, Atkinson EN and Hong WK (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non small-cell lung cancer. J Natl Cancer Inst 86: 673-680
22. Sculier JP, Paesmans M, Bureau G, Recloux P, Baumöhl J, Van Cutsem O, Berchief MC, Thiriaux J, Lafilte JJ, Mommen P, Van Houtte P, Ninane V and Klastersky J (1998) A phase III randomized study comparing, in non metastatic unresectable non-small cell lung cancer (NSCLC) responding to chemotherapy (CT), further CT to loco-regional irradiation (RT). Ann Oncol 9: 83 (abstr 399)
23. Shepherd FA, Evans WK, Goss PE, Latreille J, Logan D, Maroun J, Stewart D, Warner E and Paul K (1992) Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer. Semin. Oncol 19: 54-58
24. Shirinian M, Lee JS, Dhingra HH, Greenberg J and Hong WK (1992) Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report. Semin Oncol 19: 58-64